Zuno Medical

Coming – April 23

Join Us For Lunch With A MedTech Innovator

Date and Time

April 23

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

You are invited to join a select group of family offices for a private lunch discussion with Allan McNichol, the CEO of Zuno Medical, a Bay Area medical technology innovator that is solving the #1 constraint to surgical revenue: the sterilization bottleneck.

A single contaminated instrument set can delay or cancel surgery, costing hospitals and surgical centers $790B annually, while negatively impacting patient care.

Zuno Medical’s flagship innovation, the Zuno Smart Container, is an FDA–cleared IoT device that is already displacing disposable surgical wraps with a reusable, vacuum-sealed system.
  • Efficiency: Reduces instrument processing time by 75%.
  • Growth: Enables a 75% increase in surgical capacity within existing footprints.
  • Traction: Four live, revenue-generating deployments paying full list price.
  • Impact: Removes 300 million pounds of single-use medical plastic from the U.S. waste stream

Register today to join this lunch meeting in Palo Alto with Zuno CEO, Allan McNichol, to discuss the company’s clear clinical ROI, strong patent protection, and a recurring revenue subscription model in a massive market that is starved for innovation.

Attendance is limited. RSVP requests will be reviewed prior to confirmation. Location will be provided upon RSVP approval.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.